Notably, however, almost all instances of co‐expression of these two genes occurred within the MS subgroup (highlighted in red in Fig. 6E), with 57/68 (83.8%) of samples from patients in the MS subgroup expressing both DSG2 and CDH2. This evidence concerns the gene DSG2 and myeloid sarcoma.